Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rohto Pharmaceutical CoRPHCF 89 Graham Number is $11.64 as of Mar. 2026, which is 676% above its 10-year median of 1.50. GuruFocus rates RPHCF with a GF Score™ of 89/100 and a GF Value™ of $21.04. The stock has 2 warning signs investors should review. Among 1,386 Consumer Packaged Goods companies, Rohto Pharmaceutical Co ranks worse than 60.68% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
The historical rank and industry rank for Rohto Pharmaceutical Co's Graham Number or its related term are showing as below:
RPHCF'
s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.34 Med: 1.5 Max: 1.97
Current: 1.38
During the past 13 years, the highest Price to Graham Number ratio of Rohto Pharmaceutical Co was 1.97. The lowest was 1.34. And the median was 1.50.
RPHCF's Price-to-Graham-Number is ranked worse than 60.68% of 1386
companies
in the Consumer Packaged Goods industry
Industry Median: 1.1
vs RPHCF: 1.38
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Rohto Pharmaceutical Co (OTCPK:RPHCF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Rohto Pharmaceutical Co's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Mar. 2026 )
=
15.00
/
11.64
=
1.29
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Rohto Pharmaceutical Co Graham Number Related Terms
Rohto Pharmaceutical Co Graham Number Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rohto Pharmaceutical Co Price-to-Graham-Number vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Rohto Pharmaceutical Co's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rohto Pharmaceutical Co (RPHCF) has a Graham Number of $11.64 as of Mar. 2026. The Graham Number values a company based on its per-share earnings and book value. View historical data on Rohto Pharmaceutical Co and its competitors. This is 676% above median its historical median of 1.50. Over the past decade, Rohto Pharmaceutical Co's Graham Number has ranged from 1.34 to 1.97. According to the industry distribution chart, Rohto Pharmaceutical Co ranks #841 out of 1386 companies in the Consumer Packaged Goods industry, placing it in the top 60.7%.
Is Rohto Pharmaceutical Co's Graham Number too high?
Rohto Pharmaceutical Co's current Graham Number of $11.64 is 676% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 1.34 to a high of 1.97. The Consumer Packaged Goods industry median Graham Number is 1.10. Rohto Pharmaceutical Co's value of $11.64 is 958.2% above this industry median. Based on the distribution chart, Rohto Pharmaceutical Co ranks #841 out of 1386 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Rohto Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Graham Number compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Rohto Pharmaceutical Co ranks #841 out of 1386 companies for Graham Number. This places Rohto Pharmaceutical Co in the lower half of its industry. The industry median Graham Number is 1.10. Rohto Pharmaceutical Co's value of $11.64 is 958.2% above this benchmark. Historically, Rohto Pharmaceutical Co's own Graham Number has ranged from 1.34 to 1.97 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 1.10, Rohto Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Consumer Packaged Goods company?
The median Graham Number among Consumer Packaged Goods companies is 1.10, based on 1,386 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rohto Pharmaceutical Co's current Graham Number of $11.64 is 958.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Rohto Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median Graham Number is 1.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rohto Pharmaceutical Co's current Graham Number is $11.64, which is 676% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (RPHCF) has a current Graham Number of $11.64. The stock's GF Value™ is $21.04, compared to a current price of $15.00 — trading 28.7% below its estimated fair value. The current Graham Number is $11.64, which is 676% above median its 10-year median of 1.50 and 958.2% above the Consumer Packaged Goods industry median of 1.10. Rohto Pharmaceutical Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Rohto Pharmaceutical Co (RPHCF), the current Graham Number is $11.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rohto Pharmaceutical Co (RPHCF) Overvalued in 2026?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued.
The current stock price of $15.00 is trading 28.7% below its estimated GF Value™ of $21.04.
Key valuation signals for RPHCF:
Graham Number: $11.64 (676% above median its 10-year median of 1.50)
GF Value™: $21.04 vs. price of $15.00 (28.7% below fair value)
Industry Position: 958.2% above the Consumer Packaged Goods median (#841 of 1386)
No single metric tells the full story. See the RPHCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
89GF Score
Get the complete analysis for RPHCF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RPHCF has been successfully added to your 
